共 231 条
[1]
Dowell D(2016)CDC guideline for prescribing opioids for chronic pain - United States, 2016 MMWR Recomm Rep 65 1-49
[2]
Haegerich TM(2018)On the front lines of the opioid epidemic: rescue by naloxone Eur J Pharmacol 835 147-153
[3]
Chou R(2016)Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain Ann Intern Med 165 245-252
[4]
Skolnick P(2018)Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review Pain Manag 8 231-245
[5]
Coffin PO(2020)Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data Clin Toxicol (Phila) 58 117-123
[6]
Behar E(2016)What is known about community pharmacy supply of naloxone? A scoping review Int J Drug Policy 32 24-33
[7]
Rowe C(2017)Naloxone for outpatients at risk of opioid overdose #328 J Palliat Med 20 562-563
[8]
Santos GM(2020)Association of take-home naloxone and opioid overdose reversals performed by patients in an opioid treatment program JAMA Netw Open 3 679-686
[9]
Coffa D(2019)Vital signs: pharmacy-based naloxone dispensing - United States, 2012–2018 MMWR Morb Mortal Wkly Rep 68 46-52
[10]
Bald M(2018)Emergency physicians' attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian emergency departments CJEM. 20 2213-2215